Extracorporeal photodynamic image detection of mouse osteosarcoma in soft tissues utilizing fluorovisualization effect of acridine orange

Oncology

Volumn 70, Issue 6, 2007, Pages 465-473

  Satonaka, Haruhiko ^a   Kusuzaki, Katsuyuki ^a   Matsubara, Takao ^a   Shintani, Ken ^a   Wakabayashi, Toru ^a   Matsumine, Akihiko ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Acridine orange; Fluorovisualization; Osteosarcoma; Photodynamic diagnosis

Indexed keywords

ACRIDINE ORANGE;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLUE LIGHT; CAMERA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; FLUORESCENCE; IMAGING; INOCULATION; MALE; MOUSE; MYOSARCOMA; NONHUMAN; OSTEOSARCOMA; PHOTODYNAMICS; PRIORITY JOURNAL; SOFT TISSUE;

ACRIDINE ORANGE; ANIMALS; CELL LINE, TUMOR; FEASIBILITY STUDIES; FLUORESCENCE; FLUORESCENT DYES; MICE; OSTEOSARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 33847396970     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098874     Document Type: Article

References (37)

1. Ho CL: Clinical PET imaging - an Asian perspective. Ann Acad Med Singapore 2004;33:155-165.
2. Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jurgens H, Schober O, Rummeny EJ: Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001;177:229-236.
3. Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jurgens H, Schober O: FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001;12:479-486.
4. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I: The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT. J Nucl Med 2006;47:287-297.
5. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T, Uchida A: Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 2005;2005;25:1225-1236.
6. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Shintani K, Seto M, Matsumine A, Hosoi H, Sugimoto T, Uchida A: Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas. Photochem Photobiol 2005;81:705-709.
7. Yoshida K, Kusuzaki K, Matsubara T, Matsumine A, Kumamoto T, Komada Y, Naka N, Uchida A: Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange. Oncol Rep 2005;13:279-282.
8. Ackerman NB, Shemesha A: Localization of aminoacridine fluorescence in lung tumors of rats. JAMA 1964;187:832-833.
9. Kapuscinski J, Darzynkiewicz Z, Melamed MR: Interactions of acridine orange with nucleic acids. Properties of complexes of acridine orange with single stranded ribonucleic acid. Biochem Pharmacol 1983;32:3679-3694.
10. Kusuzaki K, Suginoshita T, Minami G, Aomori K, Takeshita H, Murata H, Hashiguchi S, Ashihara T, Hirasawa Y: Fluorovisualization effect of acridine orange on mouse osteosarcoma. Anticancer Res 2000;20:3019-3024.
11. Minehisa J, II Y, Kaneda A, Yuuzu T: Observation of fluorescence from a photosensitizer irradiated with red laser. Ouyoubutsuri 1996;65:31-35.
12. Frei KA, Bonel HM, Fridk H, Walt H, Steiner RA: Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. Br J Cancer 2004;90:805-809.
13. Ramaswamy B, Manivasager V, Chin WW, Soo KC, Olivo M: Photodynamic diagnosis of a human nasopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon. Int J Oncol 2005;26:1501-1506.
14. Zaak D, Karl A, Knuchel R, Stepp H, Hartmann A, Reich O, Bachmann A, Siebels M, Popken G, Stief C: Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 2005;96:217-222.
15. Prosst RL, Winkler S, Boehm E, Gahlen J: Thoracoscopic fluorescence diagnosis (TFD) of pleural malignancies: experimental studies. Thorax 2002;57:1005-1009.
16. Till H, Bergmann F, Metzger R, Haeberle B, Schaeffer K, von Schweinitz D, Prosst RL: Videoscopic fluorescence diagnosis of peritoneal and thoracic metastases from human hepatoblastoma in nude rats. Surg Endosc 2005;19:1483-1486.
17. Chen Y, Gryshuk A, Achilefu S, Ohulchansky T, Potter W, Zhong T, Morgan J, Chance B, Prasad PN, Henderson BW, Oseroff A, Pandey RK: A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem 2005;16:1264-1274.
18. Yamamoto J, Hirano T, Li S, Koide M, Kohno E, Inenaga C, Tokuyama T, Yokota N, Yamamoto S, Terakawa S, Namba H: Selective accumulation and strong photodynamic effects of a new photosensitizer, ATX-S10.Na (II), in experimental malignant glioma. Int J Oncol 2005;27:1207-1213.
19. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S, Yoshikawa H: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998;76:418-422.
20. Abel PD: Lethal toxicity tests - theory and methodology; Abel PD (ed): Ecotoxicology and the Marine Environment. New York, Ellis Horwood, 1991, pp 39-58.
21. Shin DS, Weber KL, Chao EY, An KN, Sim FH: Reoperation for failed prosthetic replacement used for limb salvage. Clin Orthop Relat Res 1999;358:53-63.
22. Lindner NJ, Ramm O, Hillmann A, Roedl R, Gosheger G, Brinkschmidt C, Juergens H, Winkelmann W: Limb salvage and outcome of osteosarcoma. The University of Muenster experience. Clin Orthop Relat Res 1999;358:83-89.
23. Davis AM, Bell RS, Badley EM, Yoshida K, Williams JI: Evaluating functional outcome in patients with lower extremity sarcoma. Clin Orthop Relat Res 1999;358:90-100.
24. Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M: Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005;55:41-55.
25. Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H: Value of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 1998;3:297-303.
26. Goto Y, Ihara K, Kawauchi S, Ohi R, Sasaki K, Kawai S: Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 2002;7:304-312.
27. Kusuzaki K, Murata H, Takeshita H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T, Hirasawa Y: Intracellular binding sites of acridine orange in living osteosarcoma cells. Anticancer Res 2000;20:971-976.
28. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Ashihara T, Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 2000;91:439-445.
29. Kusuzaki K, Aomori K, Suginoshita T, Minami G, Takeshita H, Murata H, Hashiguchi S, Ashihara T, Hirasawa Y: Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange. Oncology 2000;59:174-180.
30. Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T, Hirasawav Y: Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology 2005;65:85-93.
31. Kusuzaki K, Takeshita H, Murata H, Gebhardt MC, Springfield DS, Mankin HJ, Ashihara T, Hirasawa Y: Polyploidization induced by acridine orange in mouse osteosarcoma cells. Anticancer Res 2000;20:965-970.
32. Matsubara T, Kusuzaki K, Matsumine A, Shintani K, Satonaka H, Uchida A: Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. Anticancer Res 2006;26:187-194.
33. Zampieri A, Greenberg J: Mutagenesis by acridine orange and proflavine in Escherichia coli strain S. Mutat Res 1965;2:552-556.
34. McCann J, Ames BN: Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. Proc Natl Acad Sci USA 1976;73:950-954.
35. Van Duuren BL, Sivak A, Katz C, Melchionne S: Tumorigenicity of acridine orange. Br J Cancer 1969;23:587-590.
36. Acridine orange. IARC Monogr Eval Carcinog Risk Chem Man 1978;16:145-152.
37. Rice BW, Cable MD, Nelson MB: In vivo imaging of light-emitting probes. J Biomed Opt 2001;6:432-440.